Laden...
Dear E, The J.P. Morgan Healthcare Conference is in less than two weeks and there are still a few spots open to attend our FierceBiotech Executive Breakfast on January 14th. The event will run from 7:00AM-11:30AM at The Fairmont Hotel in San Francisco and will include a full breakfast buffet, two panels with visionary speakers, a closing reception sponsored by Clarivate, networking, and more. This year's speaker lineup includes: Panel One / Strategic Considerations for the Commercialization of Cell and Gene Therapies: Dr. Mitchell Finer / Chief Scientific Officer / ElevateBio David J. Lennon, Ph.D. / President / AveXis, a Novartis Company Paul Levesque / Global President of Pfizer Rare Disease / Pfizer Bill Martin / Chief Commercial Officer / Accredo and Curascript SD Opening Remarks: Keiko Oishi / President and COO / CMIC Alberto Santagostino / Head of Cell and Gene Technologies / Lonza Closing Remarks: Stephen J. Ubl / President and Chief Executive Officer / PhRMAPanel Two / The Promise of AI: Can Artificial Intelligence and Machine Learning Really Transform R&D? Alex Zhavoronkov, PhD / Founder and CEO / Insilico Medicine Registration for the event is available here. I look forward to seeing you in San Francisco. Best, Rebecca Willumson |
Click here to unsubscribe or to manage your subscriptions. ©2020 FierceMarkets, a division of Questex, LLC. All rights reserved. 1900 L St NW | Washington, DC | 20036 www.questex.com |
Laden...
Laden...